Sylentis releases topline results from phase 2a of SYL1801
SYL1801 is an investigational siRNA therapy administered via eye drops, rather than intravitreal injection, to treat nAMD.
Related Articles
Current Tips and Tricks for Maximizing DMEK Outcomes
By Samantha M. Arsenault, MD, and Rahul Tonk, MD, MBA Figure 1. Preoperative slit lamp photo of patient with Fuchs’ disease showing dense central guttae…
An Unusual Epibulbar Complex Choristoma
A 6-month-old girl presented with a growth in her right eye preventing eyelid closure. She had a protruding, keratinized, large, ill-defined, circumferential lesion involving the…
May 2025 Wills Eye Resident Case Series
Figure 1. Fundus photograph, right eye. A 64-year-old male presented with blurry vision, pain and photophobia primarily in the right eye. The patient had a…
Geographic atrophy in the real world
Retina Specialist focuses on the latest advances in the diagnosis, medical management and surgical treatment of diseases of the retina, along with practical, real-world advice…
Eyeworld – SPRING 2025
EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Ophthalmic Surgery, Lasers and Imaging Retina: Vol 56, No 5
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password?
The Influence of the Epithelium Removal Method on the Outcomes of Photorefractive Keratectomy | Journal of Refractive Surgery
Purpose To compare the outcomes and complications reported for alternative methods of removal of the corneal epithelium during photorefractive keratectomy (PRK). Methods Literature review. Results…
Clinical Trial Update May 2025
Access Retinal Physician’s listing of all active clinical trials in AMD, DME, RVO, and uveitis.
The conundrum of prolonged post-cataract corneal edema – EyeWorld
Corneal edema after cataract surgery is expected to an extent, but as postop recovery stretches to 1 month or beyond, surgeons begin to treat the…